K. Wiebes schreef op 19 oktober 2023 14:33:
www.vivoryon.com/vivoryon-therapeutic......"Pursuant to the Offering, the Company will issue 2,054,796 ordinary shares at an offering price
of EUR 7.30 per share, amounting to gross proceeds of EUR 15.0 million. The new shares issued
pursuant to the Offering represent 9.3% of Vivoryon’s existing issued share capital and will be
issued from the Company’s authorized capital under exclusion of the existing shareholders’ pre-
emptive rights. As a consequence, the Company’s issued share capital will increase to EUR
24,105,278.00 on completion of the Offering, which is expected to occur on October 6, 2022.
In addition, the investors have the option to purchase, in aggregate, up to another 2,054,796
shares during a period ending twelve months after the date of the approval of an EU Recovery
prospectus (in accordance with Section 14a Prospectus Regulation) or three months after the
achievement date of a defined clinical milestone, whichever is later, at a price of EUR 7.30 per
share"....
Ik denk dat we naar de verkoop van die tweede tranche zitten te koekeloeren. Dan zou er volgens
mij voor 't eind van de maand een bericht van uitgifte vanwege Viv. moeten komen.